138 related articles for article (PubMed ID: 7510012)
1. Successful islet allotransplantation in diabetic rats immunosuppressed with FK506: a functional and immunological study.
Tze WJ; Tai J; Cheung SS; Murase N; Starzl TE
Metabolism; 1994 Feb; 43(2):135-9. PubMed ID: 7510012
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of pig islet xenograft survival in rats immunosuppressed with FK506.
Tze WJ; Tai J; Cheung SS
Diabetes Res Clin Pract; 1997 Sep; 37(3):149-56. PubMed ID: 9306035
[TBL] [Abstract][Full Text] [Related]
3. Immunological studies in diabetic rat recipients with a pancreatic islet cell allograft in the brain.
Tze WJ; Tai J
Transplantation; 1989 Jun; 47(6):1053-7. PubMed ID: 2499961
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of purified islet cells in diabetic rats. II. Immunogenicity of allografted islet beta-cells.
Pipeleers DG; Pipeleers-Marichal M; Vanbrabandt B; Duys S
Diabetes; 1991 Jul; 40(7):920-30. PubMed ID: 2060728
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: importance of low temperature culture and transplant site on induction and maintenance.
Yasunami Y; Ryu S; Ueki M; Arima T; Kamei T; Tanaka M; Ikeda S
Cell Transplant; 1994; 3(1):75-82. PubMed ID: 7512876
[TBL] [Abstract][Full Text] [Related]
6. FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat.
Yasunami Y; Ryu S; Kamei T
Transplantation; 1990 Apr; 49(4):682-6. PubMed ID: 1691535
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of discordant pig islet xenografts in diabetic rats.
Tze WJ; Tai J; Cheung SS
Diabetes Res Clin Pract; 1992 Mar; 15(3):197-204. PubMed ID: 1576920
[TBL] [Abstract][Full Text] [Related]
8. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
Rastellini C; Cicalese L; Leach R; Braun M; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):646-7. PubMed ID: 10083278
[No Abstract] [Full Text] [Related]
10. Isolated pancreatic islet allografts in rats rendered immunologically unresponsive to renal allografts. The effect of the site of transplantation.
Gray DW; Reece-Smith H; Fairbrother B; McShane P; Morris PJ
Transplantation; 1984 May; 37(5):434-7. PubMed ID: 6233763
[TBL] [Abstract][Full Text] [Related]
11. Failure of nonimmunogenic islet allografts to induce donor-specific immunological unresponsiveness [corrected].
Ketchum RJ; Moyer C; Su HC; Moore WV
Cell Transplant; 1994; 3(2):179-86. PubMed ID: 8012733
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival of islet allografts in diabetic rats treated with FK 506.
Tze WJ; Tai J; Cheung SS; Murase N; Ricordi C; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3208-10. PubMed ID: 1721411
[No Abstract] [Full Text] [Related]
14. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.
Yang H; Issekutz TB; Wright JR
Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946
[TBL] [Abstract][Full Text] [Related]
15. The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.
Terasaka R; Lacy PE; Hauptfeld V; Bucy RP; Davie JM
Diabetes; 1986 Jan; 35(1):83-8. PubMed ID: 3079714
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
17. Human islet xenograft survival in diabetic rats. A functional and immunohistochemical study.
Tze WJ; Tai J; Cheung S
Transplantation; 1990 Mar; 49(3):502-5. PubMed ID: 2107614
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
Du CY; Xu EK
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effect of 2'-deoxycoformycin (Pentostatin) for rat islet allotransplantation.
Ar'Rajab A; Harris RB; Khair-el-Din TA; Sentementes JT; Lu C; Dawidson IJ
Cell Transplant; 1995; 4(3):315-21. PubMed ID: 7640871
[TBL] [Abstract][Full Text] [Related]
20. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
